Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Victor M. Schuettfort"'
Autor:
Hadi Mostafaei, Pawel Rajwa, Francesco Soria, Péter Nyirády, Frederik König, Pierre I. Karakiewicz, Shahrokh F. Shariat, Douglas S. Scherr, Satoshi Katayama, Yair Lotan, Benjamin Pradere, Shin Egawa, Keiichiro Mori, Nico C. Grossmann, Abdulmajeed Aydh, Fahad Quhal, Jeremy Yuen-Chun Teoh, Reza Sari Motlagh, Martin Haydter, Eva Compérat, Victor M. Schuettfort, Ekaterina Laukhtina, Marco Moschini
Publikováno v:
European Urology Focus. 8:972-979
BACKGROUND Elevated preoperative plasma levels of the angiogenesis-related marker VEGF have been associated with worse oncological outcomes in various malignancies. OBJECTIVE To investigate the predictive/prognostic role of VEGF in patients with urot
Autor:
Jeremy Yuen-Chun Teoh, Morgan Rouprêt, Hadi Mostafaei, Pierre I. Karakiewicz, Pawel Rajwa, Victor M. Schuettfort, Yasutomo Nasu, Reza Sari Motlagh, Marco Moschini, Nico C. Grossmann, Keiichiro Mori, Eva Compérat, Satoshi Katayama, Mohammad Abufaraj, Ekaterina Laukhtina, Motoo Araki, Dmitry Enikeev, Shahrokh F. Shariat, Fahad Quhal, Vitaly Margulis, Benjamin Pradere
Publikováno v:
European Urology Focus. 8:761-768
Background Among various clinicopathologic factors used to identify low-risk upper tract urothelial carcinoma (UTUC), tumor grade and stage are of utmost importance. The clinical value added by inclusion of other risk factors remains unproven. Object
Autor:
Mattia Luca Piccinelli, Stefano Luzzago, Giulia Marvaso, Ekaterina Laukhtina, Noriyoshi Miura, Victor M. Schuettfort, Keiichiro Mori, Alberto Colombo, Matteo Ferro, Francesco A. Mistretta, Nicola Fusco, Giuseppe Petralia, Barbara A. Jereczek-Fossa, Shahrokh F. Shariat, Pierre I. Karakiewicz, Ottavio de Cobelli, Gennaro Musi
Publikováno v:
World Journal of Urology. 40:1447-1454
Purpose To test any-cause discontinuation and ISUP GG upgrading rates during Active Surveillance (AS) in patients that underwent previous negative biopsies (PNBs) before prostate cancer (PCa) diagnosis vs. biopsy naive patients. Methods Retrospective
Autor:
Markus von Deimling, Victor M. Schuettfort, David D'Andrea, Benjamin Pradere, Nico C. Grossmann, Tatsushi Kawada, Takafumi Yanagisawa, Muhammad Majdoub, Ekaterina Laukhtina, Pawel Rajwa, Fahad Quhal, Hadi Mostafaei, Harun Fajkovic, Jeremy Yuen-Chun Teoh, Marco Moschini, Pierre I. Karakiewicz, Margit Fisch, Michael Rink, Shahrokh F. Shariat
Publikováno v:
Clinical Genitourinary Cancer.
Autor:
Anna Ekaterina Finger, Silke Riechardt, Roland Dahlem, Armin Soave, Michael Rink, Guido Sauter, Hendrina Contreras, Lisa Steinhilper, Margit Fisch, Malte W. Vetterlein, Victor M. Schuettfort
Publikováno v:
BJU internationalReferences.
Autor:
Noriyoshi Miura, Francesco A. Mistretta, Abdulmajeed Aydh, Stefano Luzzago, Victor M. Schuettfort, Ekaterina Laukhtina, Keiichiro Mori, Matteo Ferro, Pierre I. Karakiewicz, Giuseppe Petralia, Barbara Alicja Jereczek-Fossa, Nicola Fusco, M.L. Piccinelli, Ottavio De Cobelli, Giulia Marvaso, Shahrokh F. Shariat, Gennaro Musi
Publikováno v:
World Journal of Urology. 40:443-451
To test discontinuation rates during Active Surveillance (AS) in patients diagnosed with incidental prostate cancers (IPCa) vs. tumors diagnosed at prostate biopsies (BxPCa). Retrospective single center analysis of 961 vs. 121 BxPCa vs. IPCa patients
Autor:
Marco Moschini, Keiichiro Mori, Reza Sari Motlagh, Péter Nyirády, Victor M. Schuettfort, Fahad Quhal, Hadi Mostafaei, Axel S. Merseburger, Dmitry Enikeev, Shahrokh F. Shariat, Benjamin Pradere, Ekaterina Laukhtina
Publikováno v:
Immunotherapy. 13:917-929
Aim: We aimed to compare the mortality rates related to adverse events (AEs) and discontinuation of treatment due to toxicity as well as all AEs of currently used regimens of second-line treatment strategies for advanced or metastatic urothelial carc
Autor:
Gero Kramer, Shin Egawa, Victor M. Schuettfort, Ekaterina Laukhtina, Keiichiro Mori, Reza Sari Motlagh, Hadi Mostafaei, Mohammad Abufaraj, Pierre I. Karakiewicz, Fahad Quhal, Shahrokh F. Shariat, Takahiro Kimura, Benjamin Pradere
Publikováno v:
BJU International. 129:423-433
Objectives Management of metastatic hormone-sensitive prostate cancer (mHSPC) has undergone a paradigm shift with the use of next-generation androgen receptor inhibitors (ARIs) and docetaxel. However, direct comparative data are not available to info
Autor:
Reza Sari Motlagh, Jeremy Yuen-Chun Teoh, Shin Egawa, Benjamin Pradere, Ekaterina Laukhtina, Thomas Powles, Keiichiro Mori, Victor M. Schuettfort, Marco Moschini, Francesco Soria, Shahrokh F. Shariat, Hadi Mostafaei
Publikováno v:
European Journal of Cancer. 151:35-48
Introduction Platinum-based combination chemotherapy is the standard treatment for patients with chemotherapy-eligible metastatic urothelial carcinoma (mUC). Immune-checkpoint inhibitors (ICIs) are currently assessed in this setting. This review aime
Autor:
Keiichiro Mori, Yasutomo Nasu, Ekaterina Laukhtina, Harun Fajkovic, Marco Moschini, Satoshi Katayama, Reza Sari Motlagh, Victor M. Schuettfort, Fahad Quhal, Benjamin Pradere, Nico C. Grossmann, Hadi Mostafaei, Shahrokh F. Shariat
Publikováno v:
International Journal of Clinical Oncology
This systematic review and meta-analysis aimed to assess and compare the perioperative and oncological outcomes of intracorporeal (ICUD) and extracorporeal (ECUD) urinary diversion following robot-assisted radical cystectomy (RARC). A systematic lite